In preclinical and in-vitro studies, both peptides are being researched in relation to tissue repair: BPC-157 in connection with the formation of new blood vessels and tendon, ligament and muscle processes, and TB-500 in connection with cell migration and actin binding
Tell your doctor or pharmacist if you notice any of the following and they worry you: Diarrhoea Nausea Headache Vomiting Dizziness Acne Skin rash Pain or redness at the injection site Feeling hot or cold
The compound has also been studied in relation to inflammation signaling and tissue repair mechanisms , and it is frequently referenced in research exploring peptide-based cellular signalling pathways
TB-500 (derived from Thymosin Beta-4) Often promoted to: accelerate muscle recovery reduce inflammation improve flexibility However, current evidence is largely limited to animal and laboratory studies, and strong human clinical trial evidence is lacking
10.1016/j.ejphar.2016.02.038 41 GwyerD.WraggN
BPC-157 excellent for specific tear sites